Continuing future efforts in delineating downstream leptin signaling mechanisms regulating KATP channel trafficking in β-cells may offer novel therapeutic targets for improving glycemic control in type 2 diabetes patients by bypassing the leptin-resistance caused by obesity. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.